Results and clinical implications of the CAPARES trial

Canadian Journal of Cardiology

Volumn 16, Issue SUPPL. D, 2000, Pages

  Thaulow, Erik ^a   Jørgensen, Bjørn ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Angina; Angioplasty; Calcium channel blockers; Ischemia; Restenosis

Indexed keywords

AMLODIPINE; CALCIUM CHANNEL BLOCKING AGENT;

ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INCIDENCE; MALE; MULTICENTER STUDY; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AMLODIPINE; ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CALCIUM CHANNEL BLOCKERS; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INCIDENCE; MALE; RECURRENCE; TREATMENT OUTCOME;

EID: 0034219376     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Hamon M, Bauters C, McFadden EP, et al. Restenosis after coronary angioplasty. Eur Heart J 1995;16(Suppl I):33-48.
2. Boccara A, Benamer H, Juliard JM, et al. A randomized trial of a fixed high dose vs a weight-adjusted low dose of intravenous heparin during coronary angioplasty. Eur Heart J 1997;18:631-5.
3. Hollman J, Simpfendorfer C, Franco I, Whitlow P, Goormastic M. Multivessel and single-vessel coronary angioplasty: a comparative study. Am Heart J 1992:124:9-12.
4. Potkin BN, Keren G, Mintz GS, et al. Arterial responses to balloon coronary angioplasty: an intravascular ultrasound study. J Am Coll Cardiol 1992;20:942-51.
5. Mintz GS, Pichard AD, Kent KM, Satler LF, Popma JJ, Leon MB. Intravascular ultrasound comparison of restenotic and de novo coronary artery narrowings. Am J Cardiol 1994;74:1278-80.
6. Glagov S. Intimal hyperplasia, vascular modeling, and the restenosis problem. Circulation 1994;89:2888-91.
7. Hillegass WB, Ohman EM, Leimberger JD, Califf RM. A meta-analysis of randomized trials of calcium antagonists to reduce restenosis after coronary angioplasty. Am J Cardiol 1994;73:835-9.
8. Tanajura LF, Sousa AG, Feres F, et al. [Inefficacy of diltiazem in restenosis prevention after coronary angioplasty]. Arq Bras Cardiol 1994;62:99-102.
9. Corcos T, David PR, Val PG, et al. Failure of diltiazem to prevent restenosis after percutaneous transluminal coronary angioplasty. Am Heart J 1985;109:926-31.
10. Whitworth HB, Roubin GS, Hollman J, et al. Effect of nifedipine on recurrent stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1986;8:1271-6.
11. Hoberg E, Schwartz F, Scømig A, et al. Prevention of restenosis by verapamil. The Verapamil Angioplasty Study (VAS). Circulation 1990;82(Suppl III):428.
12. O'Keefe JH Jr, Giorgi LV, Hartzier GO, et al. Effects of diltiazem on complications and restenosis after coronary angioplasty. Am J Cardiol 1991;67:373-6.
13. Jorgensen B, Simonsen S, Endresen K, et al. Restenosis and clinical outcome in patients treated with amlodipine after angioplasty: results from the Coronary AngioPlasty Amlodipine REStenosis Study (CAPARES). J Am Coll Cardiol 2000;35:592-9.
14. Gronenschild E, Janssen J, Tijdens F. CAAS. II: A second generation system for off-line and on-line quantitative coronary angiography. Cathet Cardiovasc Diagn 1994;33:61-75.
15. Serruys PW, Foley DP, de Feyter PJ. Quantitative Coronary Angiography in Clinical Practice. Dordrecht: Kluwer Academic Publishers, 1994.
16. Rensing BJ, Hermans WR, Deckers JW, de Feyter PJ, Tijssen JG, Serruys PW. Lumen narrowing after percutaneous transluminal coronary balloon angioplasty follows a near gaussian distribution: a quantitative angiographic study in 1,445 successfully dilated lesions. J Am Coll Cardiol 1992;19:939-45.
17. Han P, Boatwright C, Ardlie NG. Effect of the calcium-entry blocking agent nifedipine on activation of human platelets and comparison with verapamil. Thromb Haemost 1983;50:513-7.
18. Nilsson J, Sjolund M, Palmberg L, Von Euler AM, Jonzon B, Thyberg J. The calcium antagonist nifedipine inhibits arterial smooth muscle cell proliferation. Atherosclerosis 1985;58:109-22.
19. Chahine RA, Feldman RL, Giles TD, et al. Randomized placebo-controlled trial of amlodipine in vasospastic angina. Amlodipine Study 160 Group. J Am Coll Cardiol 1993;21:1365-70.
20. Byington RP, Chen J, Furberg CD, Pitt B. Effect of amlodipine on cardiovascular events and procedures. J Am Coll Cardiol 1999;31 (Suppl A):314A.
21. Deanfield JE, Detry JM, Lichtlen PR, Magnani B, Sellier P, Thaulow E. Amlodipine reduces transient myocardial ischemia in patients with coronary artery disease: double-blind Orcadian Anti-Ischemia Program in Europe (CAPE Trial). J Am Coll Cardiol 1994; 24:1460-7.
22. Heusch G, Guth BD, Seitelberger R, Ross J Jr. Attenuation of exercise-induced myocardial ischemia in dogs with recruitment of coronary vasodilator reserve by nifedipine. Circulation 1987;75:482-90.